Abstract:Biomarkers are becoming an essential part of clinical development, not least because they offer a faster alternative to the conventional drug development approach and the promise of safer drugs, in greater numbers, approved more quickly. Many of the failures happen late in clinical trials, with the consequence that expenditure in clinical drug development -already a mammoth effort requiring a huge amount of money, time, and patient is increasing. The ultimate vision is to have access to therapeutic fields, a b… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.